# Myrio Therapeutics Pty Ltd.

Canonical: https://abierto.us/vendors/myrio-therapeutics-pty-ltd-znwkzf5taeu2

- UEI: ZNWKZF5TAEU2
- CAGE: Z16B2
- Parent: Affinity Biosciences International Pty Ltd.
- Location: Blackburn North, AUS
- Awards in window: 1 (1 transactions), $51,836 obligated, January 18, 2024 to January 18, 2024

## Awarding agencies

- National Institutes of Health: 1 awards, $51,836

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $51,836

## Competition

- Competed Under SAP: 1 awards

## Largest awards

- 75N92024P00043 (purchase order): $51,836, National Institutes of Health Nhlbi. Bispecific Antibodies Against CT-RCC Herv-E. https://www.usaspending.gov/award/CONT_AWD_75N92024P00043_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/myrio-therapeutics-pty-ltd-znwkzf5taeu2.
